BerandaAMBI • NYSEAMERICAN
add
Ambipar Emergency Response
Tutup sebelumnya
$0,43
Rentang hari
$0,36 - $0,42
Rentang tahun
$0,20 - $0,55
Kapitalisasi pasar
23,01Â jt USD
Volume Rata-Rata
5,39Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NYSEAMERICAN
Berita pasar
.INX
0,74%
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (BRL) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 817,26Â jt | 10,36% |
Biaya operasional | -21,56Â jt | -262,28% |
Penghasilan bersih | -99,58Â jt | -226,98% |
Margin laba bersih | -12,18 | -196,35% |
Penghasilan per saham | — | — |
EBITDA | 138,17Â jt | -17,75% |
Tarif pajak efektif | -34,76% | — |
Neraca
Total aset
Total liabilitas
| (BRL) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 358,43Â jt | -15,32% |
Total aset | 5,80Â M | 34,60% |
Total liabilitas | 3,98Â M | 34,93% |
Total ekuitas | 1,82 M | — |
Saham yang beredar | 55,43 jt | — |
Harga terhadap nilai buku | 0,02 | — |
Tingkat pengembalian aset | 3,94% | — |
Tingkat pengembalian modal | 4,63% | — |
Arus Kas
Perubahan kas bersih
| (BRL) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -99,58Â jt | -226,98% |
Kas dari operasi | 110,44Â jt | 35,69% |
Kas dari investasi | 77,48Â jt | 184,48% |
Kas dari pembiayaan | -381,16Â jt | -157,73% |
Perubahan kas bersih | -82,47Â jt | 5,91% |
Arus kas bebas | -260,36Â jt | -2.494,33% |
Tentang
Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility. Ambit made an initial public offering in May 2013, and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange. Wikipedia
Didirikan
1 Jan 2000
Kantor pusat
Karyawan
53